A pilot study by the American Society of Clinical Oncology showed that using DocuSign eSignature in clinical trials significantly improved efficiency and reduced costs. Compared to paper signatures, eSignature reduced document prep time by 20%, transaction time by 19%, and saved 612 labor hours and $25,285 over 6.5 months. Users found the process faster, more intuitive, and secure, with nearly two-thirds of signatures completed in under 2 hours. DocuSign ensured 21 CFR Part 11 compliance and offered features like audit trails, templates, and error prevention, helping streamline workflows and enhance data accuracy.

Join for free to read